Overview

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

Status:
Completed
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
For the past 130 years, appendectomy has been the standard treatment for appendicitis. Recent studies from Europe have challenged the notion that surgery is the best option, showing that antibiotics alone can treat appendicitis without a need for appendectomy in as many as 3 out of 4 patients and without safety issues for up to one year of follow up. Despite these results, it remains to be determined if the antibiotic strategy is as good as an appendectomy for the outcomes that most patients care about. The Patient-Centered Outcomes Research Institute (PCORI)-funded Comparison of Outcomes of Drugs and Appendectomy (CODA) trial will be the first American, and largest-ever randomized trial of the issue and its results should help surgeons and patients make more informed healthcare decisions.
Phase:
N/A
Details
Lead Sponsor:
University of Washington
Collaborator:
Patient-Centered Outcomes Research Institute
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefazolin
Cefotaxime
Cefoxitin
Ceftriaxone
Cefuroxime
Cefuroxime axetil
Ciprofloxacin
Clavulanic Acid
Clavulanic Acids
Ertapenem
Levofloxacin
Metronidazole
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Ofloxacin
Ticarcillin
Ticarcillin-clavulanic acid
Tigecycline